Publications en collaboration avec des chercheurs de Centro de Investigación Príncipe Felipe (13)

2020

  1. Dapagliflozin does not modulate atherosclerosis in mice with insulin resistance

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-18

2019

  1. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  2. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis

    Diabetologia, Vol. 62, Núm. 11, pp. 2143-2157

  3. Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes

    Journal of Translational Medicine, Vol. 17, Núm. 1

2016

  1. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/lymphotoxin β-receptor pathway

    Thrombosis and Haemostasis, Vol. 116, Núm. 2, pp. 379-393

2015

  1. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis

    Journal of Endocrinology, Vol. 227, Núm. 3, pp. 179-191

  2. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, Núm. 9, pp. 1729-1742

2014

  1. Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis

    Cardiovascular Research, Vol. 103, Núm. 2, pp. 324-336

2013

  1. Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging

    Aging Cell, Vol. 12, Núm. 1, pp. 102-111

2011

  1. Deficient p27 phosphorylation at serine 10 increases macrophage foam cell formation and aggravates atherosclerosis through a proliferation-independent mechanism

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Núm. 11, pp. 2455-2463

2008

  1. Molecular mechanisms of atherosclerosis in metabolic syndrome: Role of reduced IRS2-dependent signaling

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 28, Núm. 12, pp. 2187-2194

2007

  1. Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis

    Frontiers in Bioscience, Vol. 12, Núm. 12, pp. 4439-4455

  2. Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice

    Frontiers in Bioscience, Vol. 12, Núm. 6, pp. 2291-2298